Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
Surgery Partners Stock

Surgery Partners Stock SGRY

SGRY
US86881A1007
A14YWP

Price

23.85
Today +/-
-0.13
Today %
-0.65 %

Surgery Partners stock price

Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Surgery Partners stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Surgery Partners stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Surgery Partners stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Surgery Partners's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Surgery Partners Stock Price History

DateSurgery Partners Price
8/20/202523.85 undefined
8/20/202524.01 undefined
8/19/202523.21 undefined
8/18/202522.60 undefined
8/15/202522.81 undefined
8/14/202522.69 undefined
8/13/202523.55 undefined
8/12/202522.96 undefined
8/11/202522.75 undefined
8/8/202523.82 undefined
8/7/202523.18 undefined
8/6/202522.51 undefined
8/5/202522.51 undefined
8/4/202521.96 undefined
7/31/202521.28 undefined
7/30/202521.95 undefined
7/29/202522.37 undefined
7/28/202522.33 undefined
7/27/202522.44 undefined
7/25/202521.14 undefined
7/24/202521.31 undefined
7/23/202522.31 undefined
7/22/202522.94 undefined

Surgery Partners Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Surgery Partners, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Surgery Partners from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Surgery Partners’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Surgery Partners. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Surgery Partners’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Surgery Partners’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Surgery Partners’s growth potential.

Surgery Partners Revenue, EBIT and net profit per share

DateSurgery Partners RevenueSurgery Partners EBITSurgery Partners Net Income
2029e5.09 B undefined0 undefined315.18 M undefined
2028e4.62 B undefined0 undefined254.72 M undefined
2027e4.14 B undefined542.01 M undefined173 M undefined
2026e3.76 B undefined528.69 M undefined142.89 M undefined
2025e3.44 B undefined460.49 M undefined113.25 M undefined
20243.11 B undefined474.3 M undefined-168.1 M undefined
20232.74 B undefined414.9 M undefined-11.9 M undefined
20222.54 B undefined374.5 M undefined-54.6 M undefined
20212.23 B undefined304.1 M undefined-81.2 M undefined
20201.86 B undefined188.8 M undefined-155.6 M undefined
20191.83 B undefined260.1 M undefined-110.5 M undefined
20181.77 B undefined249.1 M undefined-238.1 M undefined
20171.34 B undefined171.1 M undefined-79 M undefined
20161.15 B undefined200.2 M undefined9.5 M undefined
2015959.9 M undefined176.5 M undefined1.4 M undefined
2014403.3 M undefined93 M undefined-65.9 M undefined
2013284.6 M undefined70.8 M undefined-9.1 M undefined
2012260.2 M undefined61.3 M undefined1.9 M undefined
2011177.9 M undefined29.7 M undefined-26.3 M undefined

Surgery Partners Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
0.180.260.280.40.961.151.341.771.831.862.232.542.743.113.443.764.144.625.09
-46.899.2341.90137.9719.4017.1232.073.391.5819.6214.118.0313.5310.579.2110.1911.5110.19
38.4244.2345.0741.6934.9332.8429.1628.0127.8025.1126.1625.8826.6926.8124.2522.2120.1518.0716.40
6811512816833537639149650946758265773283500000
-261-9-6519-79-238-110-155-81-54-11-168113142173254315
--103.85-1,000.00622.22-101.54800.00-977.78201.27-53.7840.91-47.74-33.33-79.631,427.27-167.2625.6621.8346.8224.02
48.248.248.248.237.548.248.34848.348.872.492125.61126.1200000
-------------------
Details

Keystats

ⓘ

Revenue and Growth

The Surgery Partners Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Surgery Partners is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (B)
TANGIBLE ASSETS (B)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
201320142015201620172018201920202021202220232024
                       
1374.957.969.7174.9184.392.7317.9389.9282.9195.9269.5
54.4145177.8220.6288307.6326.9382.2430.2456.3496.4579.1
1.18.619.89.514.208.600000
4.623.725.628.84543.446.356.461.171.475.288.4
9.516.529.833.441.153514564.9110.4127.5182.4
0.080.270.310.360.560.590.530.80.950.920.91.12
0.020.180.180.20.40.430.820.850.951.161.221.38
0.53636.939.577.778.893.590.688.7190.3184.1215.4
00.20.20.72.30000000
2754.953.64858.954.347.346.943.742.354.845.7
0.341.31.411.563.353.383.43.473.914.144.335.07
4.425.4110.395.3175.3145.7129.2151.5173.5235.7192.857.5
0.391.591.791.944.064.094.494.615.175.765.986.77
0.471.862.12.314.624.685.025.416.126.686.887.89
                       
000.50.5331.3359.8395.54350.91.31.31.3
0.060.060.320.320.70.670.660.611.622.482.52.52
-163.3-322.2-320.8-311.4-41.3-247-315.7-431.8-502.7-557.3-569.2-737.3
00000-22.4-50.7-61-31.576.257.54.8
000000000000
-0.1-0.26-00.010.990.760.690.551.0921.991.79
18.343.145.349.884.783.396.7100.2124.9151.6171.8208.7
1146.353.971122.9183.4228.9223.4215190.3219.9257.7
4.329.954.938.136.720.116.5168.8136.588.75856.6
000000000000
8.822.127.227.858.762.65664.460.462.873.3101.4
42.4141.4181.3186.7303349.4398.1556.8536.8493.4523624.4
0.421.391.281.472.252.422.522.792.882.562.73.27
1649.200000000039.2
1256.1159.7146100.9121.4396.7440.6402.6346.8290322.3
0.451.51.441.612.352.542.923.233.282.912.993.63
0.491.641.621.82.662.893.323.793.823.43.514.25
0.391.371.621.813.643.664.014.344.915.45.56.04
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Surgery Partners provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Surgery Partners's financial health and stability.

Assets

Surgery Partners's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Surgery Partners must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Surgery Partners after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Surgery Partners's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
201220132014201520162017201820192020202120222023
2517-27728528-954517087135
11111534395167769498114118
5714-149652258-21821-1
-5-10-19-44-43-2133-6875-149-160-63
923401783991237811075114123
2431509679109145180203194218169
000101211111
4649218412512014412924687158293
-4-4-9-33-39-29-39-73-42-57-80-88
-3-3-271-134-184-783-128-85-88-331-307-225
1,0000-261,000-101,000-145,000-753,000-89,000-11,000-45,000-274,000-227,000-136,000
000000000000
-19123467-139172623118-1213-43-65519
00-32510308-2005818820
-43-373113371767-6-1356631642-155
-23.00-160.00-153.00-78.00-101.00-162.00-115.00-134.00-146.00-216.00-185.00-174.00
00000-1-700-500
0761-16111059-9122571-107-87
41.744.912.551.186.191.3104.855.920429.578.2205
000000000000

Surgery Partners stock margins

The Surgery Partners margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Surgery Partners. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Surgery Partners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Surgery Partners's sales revenue. A higher gross margin percentage indicates that the Surgery Partners retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Surgery Partners's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Surgery Partners's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Surgery Partners's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Surgery Partners. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Surgery Partners's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Surgery Partners Margin History

Surgery Partners Gross marginSurgery Partners Profit marginSurgery Partners EBIT marginSurgery Partners Profit margin
2029e26.82 %0 %6.19 %
2028e26.82 %0 %5.51 %
2027e26.82 %13.08 %4.18 %
2026e26.82 %14.06 %3.8 %
2025e26.82 %13.37 %3.29 %
202426.82 %15.23 %-5.4 %
202326.7 %15.12 %-0.43 %
202225.89 %14.75 %-2.15 %
202126.16 %13.67 %-3.65 %
202025.12 %10.15 %-8.37 %
201927.81 %14.2 %-6.03 %
201828.04 %14.06 %-13.44 %
201729.21 %12.76 %-5.89 %
201632.86 %17.48 %0.83 %
201534.94 %18.39 %0.15 %
201441.78 %23.06 %-16.34 %
201345.26 %24.88 %-3.2 %
201244.24 %23.56 %0.73 %
201138.22 %16.69 %-14.78 %

Surgery Partners Stock Sales Revenue, EBIT, Earnings per Share

The Surgery Partners earnings per share therefore indicates how much revenue Surgery Partners has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Surgery Partners earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Surgery Partners's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Surgery Partners’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Surgery Partners's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Surgery Partners Revenue, EBIT and net profit per share

DateSurgery Partners Sales per ShareSurgery Partners EBIT per shareSurgery Partners Earnings per Share
2029e40.37 undefined0 undefined2.5 undefined
2028e36.63 undefined0 undefined2.02 undefined
2027e32.85 undefined0 undefined1.37 undefined
2026e29.81 undefined0 undefined1.13 undefined
2025e27.3 undefined0 undefined0.9 undefined
202424.69 undefined3.76 undefined-1.33 undefined
202321.84 undefined3.3 undefined-0.09 undefined
202227.6 undefined4.07 undefined-0.59 undefined
202130.73 undefined4.2 undefined-1.12 undefined
202038.12 undefined3.87 undefined-3.19 undefined
201937.92 undefined5.39 undefined-2.29 undefined
201836.91 undefined5.19 undefined-4.96 undefined
201727.77 undefined3.54 undefined-1.64 undefined
201623.76 undefined4.15 undefined0.2 undefined
201525.6 undefined4.71 undefined0.04 undefined
20148.37 undefined1.93 undefined-1.37 undefined
20135.9 undefined1.47 undefined-0.19 undefined
20125.4 undefined1.27 undefined0.04 undefined
20113.69 undefined0.62 undefined-0.55 undefined

Surgery Partners business model

Surgery Partners Inc is an American company specializing in specialized surgical services in the United States. It was founded in 1997 and is headquartered in Nashville, Tennessee. The company focuses on outpatient surgical procedures, providing a variety of medical services including eye surgery, endoscopy, ENT surgery, gynecology, orthopedic surgery, plastic surgery, and urology. Surgery Partners has over 180 surgical centers and practices in 32 states. It expanded its services through the acquisition of Symbion Healthcare in 2017, offering anesthesia services, pain management, diagnostics, and laboratory services. The company also emphasizes excellent service and has partnerships with hospitals to expand its surgical services. Surgery Partners is one of the most popular companies on Eulerpool.com.

Surgery Partners SWOT Analysis

Strengths

  • Strong reputation in the healthcare industry as a leading provider of surgical services.
  • Extensive network of surgical facilities that enables widespread reach and convenience for patients.
  • Well-established relationships with healthcare professionals and insurance providers.
  • Continual investment in state-of-the-art technology and equipment to enhance surgical procedures and patient outcomes.

Weaknesses

  • Exposed to potential risks associated with changes in government healthcare policies and regulations.
  • Reliance on third-party payers for a significant portion of its revenue, making it susceptible to reimbursement changes.
  • Limited geographical presence in certain regions, reducing access to potential patients.
  • High dependency on skilled healthcare professionals, which could lead to labor shortages or increased costs.

Opportunities

  • Increasing demand for outpatient surgical services driven by advancements in medical technology and the preference for cost-effective treatments.
  • Potential expansion into underserved markets or partnership opportunities with local providers for greater market penetration.
  • Collaborations with insurance companies to negotiate favorable reimbursement contracts and increase patient referrals.
  • Growing trend towards value-based healthcare, providing an opportunity to differentiate through quality outcomes and efficient care delivery.

Threats

  • Intense competition from other surgical service providers, including hospitals and ambulatory surgery centers.
  • Regulatory changes that may impact reimbursement rates or require costly adjustments to compliance measures.
  • Economic downturns or changes in healthcare spending patterns that could reduce patient demand for surgical procedures.
  • Potential litigation risks from malpractice claims or allegations of medical negligence.

Surgery Partners Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Surgery Partners Revenue by Segment

Segmente2018201720162015
Healthcare Organization, Patient Service1.74 B USD---
Other24.94 M USD---
Optical services9.55 M USD---

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Surgery Partners Revenue by Segment

Segmente2018201720162015
Surgical facility services1.68 B USD564.46 M USD1.04 B USD-
Ancillary services79.63 M USD24.66 M USD90.84 M USD-
Ancillary Services---61.18 M USD
Optical services9.55 M USD3.49 M USD12.51 M USD-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Surgery Partners Revenue by Segment

Segmente2018201720162015
Surgical Facility Services---884.14 M USD
Optical Services---14.57 M USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Surgery Partners Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Surgery Partners historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Surgery Partners shares outstanding

The number of shares was Surgery Partners in 2024 — This indicates how many shares 126.122 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Surgery Partners earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Surgery Partners's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Surgery Partners’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Surgery Partners's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Surgery Partners.

Surgery Partners latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20250.14 0.17  (24.18 %)2025 Q2
3/31/20250.05 0.04  (-24.39 %)2025 Q1
12/31/20240.38 0.44  (14.97 %)2024 Q4
9/30/20240.26 0.19  (-26.04 %)2024 Q3
6/30/20240.2 0.21  (2.99 %)2024 Q2
3/31/20240.07 0.1  (36.99 %)2024 Q1
12/31/20230.39 0.44  (13.87 %)2023 Q4
9/30/20230.17 0.19  (14.18 %)2023 Q3
6/30/20230.08 0.28  (238.57 %)2023 Q2
3/31/20230 0.08  (1,900 %)2023 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Surgery Partners stock

Eulerpool World ESG Rating (EESG©)

20/ 100

🌱 Environment

5

👫 Social

29

🏛️ Governance

25

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Surgery Partners shareholders

%
Name
Stocks
Change
Date
39.60211 % Bain Capital Private Equity, LP49,946,97206/30/2025
10.27173 % Janus Henderson Investors12,954,9161,311,8656/30/2025
6.58345 % Fidelity Management & Research Company LLC8,303,180808,2766/30/2025
5.68706 % The Vanguard Group, Inc.7,172,62820,8356/30/2025
5.55018 % Pentwater Capital Management LP7,000,0004,258,0006/30/2025
4.93570 % King Street Capital Management, L.P.6,225,0001,225,0006/30/2025
4.10647 % BlackRock Institutional Trust Company, N.A.5,179,156-173,7276/30/2025
3.39022 % ClearBridge Investments, LLC4,275,807181,2496/30/2025
3.06946 % Dimensional Fund Advisors, L.P.3,871,259231,6036/30/2025
2.37959 % Fidelity Institutional Asset Management3,001,186389,9156/30/2025
1
2
3
4
5
...
10

Surgery Partners Executives and Management Board

Mr. J. Eric Evans

(47)
Surgery Partners Chief Executive Officer, Director (since 2019)
Compensation 6.46 M

Mr. David Doherty

(51)
Surgery Partners Chief Financial Officer, Executive Vice President
Compensation 3.52 M

Ms. Jennifer Baldock

(53)
Surgery Partners Executive Vice President, Chief Administrative and Development Officer
Compensation 3.09 M

Mr. Harrison Bane

(37)
Surgery Partners President, American Group
Compensation 2.43 M

Ms. Marissa Brittenham

(39)
Surgery Partners Executive Vice President, Chief Strategy Officer
Compensation 1.68 M
1
2
3
4

Most common questions regarding Surgery Partners

What values and corporate philosophy does Surgery Partners represent?

Surgery Partners Inc values the highest standards of patient care, innovation, and excellence in healthcare services. With a patient-centric approach, the company strives to provide the most advanced surgical solutions and personalized care. The corporate philosophy revolves around compassionate healthcare delivery, continuous improvement, and ethical practices. Surgery Partners Inc is committed to fostering strong relationships with physicians, patients, and partners, while maintaining a focus on operational efficiency and financial strength. The company's dedication to quality outcomes, cutting-edge technology, and commitment to patient satisfaction embodies its core values and corporate philosophy.

In which countries and regions is Surgery Partners primarily present?

Surgery Partners Inc is primarily present in the United States.

What significant milestones has the company Surgery Partners achieved?

Surgery Partners Inc has achieved several significant milestones in its history. One notable accomplishment includes the strategic acquisition of National Surgical Healthcare in 2017, which expanded the company's reach and capabilities in the outpatient surgical market. Additionally, Surgery Partners Inc achieved recognition as a leader in ambulatory surgery, providing high-quality healthcare services across multiple states. The company has also demonstrated consistent growth and financial performance, further establishing its position in the healthcare industry. Surgery Partners Inc continues to prioritize patient care and innovation, driving its success and reinforcing its reputation as an esteemed company in the stock market.

What is the history and background of the company Surgery Partners?

Surgery Partners Inc is a leading healthcare services company with an extensive history in the industry. Established in 2004, Surgery Partners has since grown to become a prominent player in providing surgical services across the United States. With a focus on delivering high-quality care in a cost-effective manner, the company operates a network of surgical facilities and ancillary services centers. Through strategic partnerships, Surgery Partners offers a range of surgical procedures in various specialties, ensuring access to a wide range of patients in need. With their commitment to exceptional patient care, Surgery Partners Inc has established itself as a trusted name in the healthcare sector.

Who are the main competitors of Surgery Partners in the market?

The main competitors of Surgery Partners Inc in the market include Tenet Healthcare Corporation, HCA Healthcare, and UnitedHealth Group.

In which industries is Surgery Partners primarily active?

Surgery Partners Inc is primarily active in the healthcare industry. With a focus on providing surgical services, the company operates a network of outpatient surgical facilities, physician practices, and anesthesia services. By offering a comprehensive range of surgical solutions, Surgery Partners Inc aims to improve patient outcomes and enhance healthcare delivery. With its expertise in specialties such as orthopedics, gastroenterology, and ophthalmology, the company plays a crucial role in meeting the diverse healthcare needs of patients across different regions. Overall, Surgery Partners Inc's activities support the advancement and accessibility of quality healthcare services.

What is the business model of Surgery Partners?

The business model of Surgery Partners Inc centers around providing a comprehensive range of surgical services through its network of ambulatory surgery centers, surgical hospitals, and contract services. With a focus on delivering high-quality, cost-effective care, Surgery Partners Inc aims to meet the needs of patients, physicians, and healthcare facilities. By offering a diverse range of surgical specialties, including orthopedics, gastroenterology, and ophthalmology, Surgery Partners Inc strives to improve patient outcomes and satisfaction. Through its strategic partnerships and operational expertise, the company continues to expand its footprint and strengthen its position within the healthcare industry.

What is the P/E ratio of Surgery Partners 2025?

The Surgery Partners P/E ratio is 26.56.

What is the P/S ratio of Surgery Partners 2025?

The Surgery Partners P/S ratio is 0.87.

What is the Quality Investing of Surgery Partners?

The Quality Investing for Surgery Partners is 6/10.

What is the revenue of Surgery Partners 2025?

The expected Surgery Partners revenue is 3.44 B USD.

How high is the profit of Surgery Partners 2025?

The expected Surgery Partners profit is 113.25 M USD.

What is the business model of Surgery Partners

Surgery Partners Inc. is a leading healthcare company that focuses on outpatient surgical centers and services for the healthcare industry. The company offers a variety of surgical and diagnostic services delivered on an outpatient basis. Surgery Partners Inc. operates over 180 facilities in 31 states in the USA and provides a wide range of surgical services. The business model of Surgery Partners Inc. is based on the goal of providing its patients with top-quality surgical services and continuous medical care at the highest level. The company has an extensive network of outpatient surgical centers and offers its patients a wide range of surgical and diagnostic services, including general surgery, orthopedics, ophthalmology, neurology, gastroenterology, gynecology, and many others. Surgery Partners Inc. also offers specialized procedures and services such as endoscopic examinations, imaging services, pain therapy, and rehabilitation. The company also operates an extensive diagnostic platform that includes advanced imaging technology and diagnostic procedures such as endoscopy and biopsy. The company also has a focus on the development and utilization of cutting-edge technology in surgery and diagnostics to ensure that patients receive excellent medical care. Surgery Partners Inc. also maintains extensive partnerships with healthcare providers and hospitals to enable better coordinated care. The company collaborates with numerous facilities to meet the needs of patients and provide them with a seamless healthcare experience. These partnerships allow Surgery Partners Inc. to expand its network of facilities and improve its services. Surgery Partners Inc. is also actively involved in research and development, working to develop new procedures and technologies to improve surgical services. The company has a strong team of researchers and physicians who continuously seek new opportunities to enhance surgery and diagnostics, thereby ensuring better healthcare. Overall, the business model of Surgery Partners Inc. is focused on providing top-quality surgical and diagnostic services on an outpatient basis. The company operates an extensive network of surgical facilities and offers a wide range of surgical and diagnostic services to meet the needs of its patients. Through healthcare partnerships and the use of cutting-edge technologies, Surgery Partners Inc. strives to provide better healthcare for its patients.

What is the Surgery Partners dividend?

Surgery Partners pays a dividend of 0 USD distributed over payouts per year.

How often does Surgery Partners pay dividends?

The dividend cannot currently be calculated for Surgery Partners or the company does not pay out a dividend.

What is the Surgery Partners ISIN?

The ISIN of Surgery Partners is US86881A1007.

What is the Surgery Partners WKN?

The WKN of Surgery Partners is A14YWP.

What is the Surgery Partners ticker?

The ticker of Surgery Partners is SGRY.

How much dividend does Surgery Partners pay?

Over the past 12 months, Surgery Partners paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgery Partners is expected to pay a dividend of 0 USD.

What is the dividend yield of Surgery Partners?

The current dividend yield of Surgery Partners is .

When does Surgery Partners pay dividends?

Surgery Partners pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgery Partners?

Surgery Partners paid dividends every year for the past 0 years.

What is the dividend of Surgery Partners?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgery Partners located?

Surgery Partners is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgery Partners kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgery Partners from 8/21/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/21/2025.

When did Surgery Partners pay the last dividend?

The last dividend was paid out on 8/21/2025.

What was the dividend of Surgery Partners in the year 2024?

In the year 2024, Surgery Partners distributed 0 USD as dividends.

In which currency does Surgery Partners pay out the dividend?

The dividends of Surgery Partners are distributed in USD.

All fundamentals about Surgery Partners

Our stock analysis for Surgery Partners Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgery Partners Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.